The Cancer Research Institute (CRI) has been a pioneer in using immunotherapy to treat cancer for 65 years. Their mission is singular, saving lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.
This week, I was fortunate enough to chat with Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs at CRI. During our discussion we unpacked the future of oncology research, the upcoming CRI Awards Gala, what it’s like working alongside a Nobel Prize winner, and Jill’s love of baking.
Since CRI is a client I am familiar with all the incredible work that they do, but it was nice to be reminded of just how revolutionary this organization is. Take a listen below.